首页> 外国专利> EXTRACELLULAR HISTONES AS BIOMARKERS FOR PROGNOSIS AND MOLECULAR TARGETS FOR THERAPY

EXTRACELLULAR HISTONES AS BIOMARKERS FOR PROGNOSIS AND MOLECULAR TARGETS FOR THERAPY

机译:胞外组蛋白作为预后的生物标志物和治疗的分子靶标

摘要

Hyper-inflammatory responses can lead to a variety of diseases including sepsis. It is now shown that extracellular histones released in response to inflammatory challenge are mediators contributing to endothelial dysfunction, organ failure and death during sepsis. As such, they can be targeted pharmacologically by inhibitors, as well as used as biomarkers for prognosis of sepsis and other diseases.
机译:过度炎症反应可导致包括败血症在内的多种疾病。现在已经表明,响应于炎症激发而释放的细胞外组蛋白是导致败血症期间内皮功能障碍,器官衰竭和死亡的介质。这样,它们可以被抑制剂药理靶向,也可以用作败血症和其他疾病预后的生物标记。

著录项

  • 公开/公告号US2018092961A1

    专利类型

  • 公开/公告日2018-04-05

    原文格式PDF

  • 申请/专利权人 OKLAHOMA MEDICAL RESEARCH FOUNDATION;

    申请/专利号US201715838639

  • 发明设计人 CHARLES T. ESMON;JUN XU;XIAOMEI ZHANG;

    申请日2017-12-12

  • 分类号A61K38/10;A61K39/395;A61K38/48;C07K7/08;A61K45/06;C07K16/18;A61K31/727;A61K38/17;

  • 国家 US

  • 入库时间 2022-08-21 13:00:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号